DK1102770T3 - Parmamagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceuticals containing them, methods for their preparation and their use in necrosis and infarct MRI imaging - Google Patents

Parmamagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceuticals containing them, methods for their preparation and their use in necrosis and infarct MRI imaging

Info

Publication number
DK1102770T3
DK1102770T3 DK99936616T DK99936616T DK1102770T3 DK 1102770 T3 DK1102770 T3 DK 1102770T3 DK 99936616 T DK99936616 T DK 99936616T DK 99936616 T DK99936616 T DK 99936616T DK 1102770 T3 DK1102770 T3 DK 1102770T3
Authority
DK
Denmark
Prior art keywords
necrosis
methods
parmamagnetic
infarct
preparation
Prior art date
Application number
DK99936616T
Other languages
Danish (da)
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Thomas Frenzel
Bernd Misselwitz
Wolfgang Ebert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1102770T3 publication Critical patent/DK1102770T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Abstract

The invention relates to paramagnetic 3-,8-substituted deuteroporphyrin derivatives having different substituents in positions 13 and 17 of the porphyrin skeleton, diagnostic substances containing said compounds, their use in magnetic resonance imaging of necrosis and infarction and methods for producing said compounds and substances.
DK99936616T 1998-07-24 1999-07-15 Parmamagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceuticals containing them, methods for their preparation and their use in necrosis and infarct MRI imaging DK1102770T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19835082A DE19835082A1 (en) 1998-07-24 1998-07-24 Paramagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical compositions containing them, processes for their preparation and their use for necrosis and infarct MR imaging
PCT/EP1999/005522 WO2000005235A1 (en) 1998-07-24 1999-07-15 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction

Publications (1)

Publication Number Publication Date
DK1102770T3 true DK1102770T3 (en) 2003-12-01

Family

ID=7876347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936616T DK1102770T3 (en) 1998-07-24 1999-07-15 Parmamagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceuticals containing them, methods for their preparation and their use in necrosis and infarct MRI imaging

Country Status (11)

Country Link
EP (1) EP1102770B1 (en)
JP (1) JP2002521384A (en)
AT (1) ATE247659T1 (en)
AU (1) AU5164699A (en)
DE (2) DE19835082A1 (en)
DK (1) DK1102770T3 (en)
ES (1) ES2205863T3 (en)
NO (1) NO317788B1 (en)
PT (1) PT1102770E (en)
TW (1) TW553941B (en)
WO (1) WO2000005235A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
CA2448570A1 (en) 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
AU2003248763A1 (en) * 2002-06-28 2004-01-19 Pharmacia Corporation Methods and contrast agents useful in quantifying nitric oxide
DE10240343A1 (en) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrite rearrangement catalysts
WO2012105483A1 (en) * 2011-01-31 2012-08-09 国立大学法人宇都宮大学 Method for producing metal complex of compound that has porphyrin skeleton

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5612016A (en) * 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
DE3827940A1 (en) * 1988-08-13 1990-03-01 Schering Ag 13,17-PROPIONIC ACID AND PROPIONIC ACID DERIVATIVE SUBSTITUTED PORPHYRINE COMPLEX COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE4232925A1 (en) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical compositions containing them and process for their preparation
JPH10500122A (en) * 1994-05-11 1998-01-06 シエーリング アクチェンゲゼルシャフト Use of porphyrin complex or extended porphyrin complex compound as infarct localization diagnostic agent
DE19824653A1 (en) * 1998-02-25 1999-08-26 Schering Ag Use of compounds concentrating in necrotic tissue as drug depots, e.g. for radiation therapy, pharmacotherapy, restenosis prevention and diagnosis

Also Published As

Publication number Publication date
DE59906695D1 (en) 2003-09-25
DE19835082A1 (en) 2000-02-03
NO317788B1 (en) 2004-12-13
JP2002521384A (en) 2002-07-16
ATE247659T1 (en) 2003-09-15
ES2205863T3 (en) 2004-05-01
NO20010392L (en) 2001-03-23
EP1102770A1 (en) 2001-05-30
NO20010392D0 (en) 2001-01-23
PT1102770E (en) 2004-01-30
AU5164699A (en) 2000-02-14
TW553941B (en) 2003-09-21
EP1102770B1 (en) 2003-08-20
WO2000005235A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
Albrand et al. The use of transferred nuclear Overhauser effects in the study of the conformations of small molecules bound to proteins
WO2000030688A3 (en) Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
ES2087938T3 (en) USE OF CHELATED COMPLEXES.
DK0874645T3 (en) Perflouralkyl-containing metal complexes and their use in NMR diagnostics
Xia et al. Clean STD‐NMR spectrum for improved detection of ligand‐protein interactions at low concentration of protein
DK1102770T3 (en) Parmamagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceuticals containing them, methods for their preparation and their use in necrosis and infarct MRI imaging
Zech et al. Probing the water coordination of protein‐targeted MRI contrast agents by pulsed ENDOR spectroscopy
BR9508435A (en) Macrocyclic chelates and their chelates and their uses in the diagnostic field
DE69120826T2 (en) CHELATE-MAKING AGENTS
Rizzi et al. Structure and single crystal EPR study of Cu (II)(l-threonine) 2· H2O
Kövér et al. 15N and 13C Group‐Selective Techniques Extend the Scope of STD NMR Detection of Weak Host–Guest Interactions and Ligand Screening
Yamamoto et al. NMR investigation of the heme electronic structure in deoxymyoglobin possessing a fluorinated heme
Krishnamoorthi et al. A 1H NMR comparison of the met-cyano complexes of elephant and sperm whale myoglobin. Assignment of labile proton resonances in the heme cavity and determination of the distal glutamine orientation from relaxation data.
Yamamoto et al. 19 F NMR study of protein-induced rhombic perturbations on the electronic structure of the active site of myoglobin
de la Fuente et al. EPR study of the 1: 1 complexes of chromium (III) and copper (II) with 5′-GMP and 5′-CMP
Pezeshk et al. Drug-metal interactions: spectroscopic studies of copper hydantoin complexes
AU7353400A (en) Macrocyclic chelants for metallopharmaceuticals